Eculizumab for refractory thrombosis in antiphospholipid syndrome

Complement in Hemolysis- and Thrombosis- Related Diseases

(2020) Shanshan Luo et al.   Frontiers in Immunology

Evidence of complement activation in the thrombotic small vessels of a patient with catastrophic antiphospholipid syndrome treated with eculizumab

(2019) Amelia Ruffatti et al.   AUTOIMMUNITY REVIEWS

Eculizumab in refractory catastrophic antiphospholipid syndrome: a case report and systematic review of the literature

(2019) Maria Giulia Tinti et al.   CLINICAL AND EXPERIMENTAL MEDICINE

Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS

(2019) Shruti Chaturvedi et al.   BLOOD

OUP accepted manuscript

(2018)   RHEUMATOLOGY

Adverse Effects of Immunoglobulin Therapy

(2018) Yi Guo et al.   Frontiers in Immunology

Eculizumab in a pregnant patient with laboratory onset of catastrophic antiphospholipid syndrome

(2018) Patrizia Rovere-Querini et al.   MEDICINE

Complement activation in antiphospholipid syndrome and its inhibition to prevent rethrombosis after arterial surgery

(2015) P. L. Meroni et al.   BLOOD

Efficacy of Eculizumab in a Patient With Immunoadsorption-Dependent Catastrophic Antiphospholipid Syndrome

(2014) Andreas Kronbichler et al.   MEDICINE

Catastrophic antiphospholipid syndrome: how to diagnose a rare but highly fatal disease

(2013) Cassyanne L. Aguiar et al.   Therapeutic Advances in Musculoskeletal Disease

Brief Report: Induction of sustained remission in recurrent catastrophic antiphospholipid syndrome via inhibition of terminal complement with eculizumab

(2012) Iuliana Shapira et al.   ARTHRITIS AND RHEUMATISM